Blood test and treatment for vivax malaria in Ethiopia and Madagascar
Part of Infections clinical trials.
This trial tests whether using a blood test to find and treat people infected with a type of malaria called Plasmodium vivax can reduce the spread of the disease. It may help you and your community stay healthier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You plan to stay in the study area for at least the next month.
- You are older than 12 months (so babies under 1 year old cannot join).
- You agree to take part and are willing to follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well a malaria treatment plan works for people with P. vivax malaria who don’t have another malaria type at the same time. It aims to see whether adding or using different medicines (ACT vs chloroquine with tafenoquine) helps clear infection and prevent return of disease.
This study tests a new combination of two medicines, SJ733 and tafenoquine, to see if it can safely and quickly cure vivax malaria. Vivax malaria can come back, so this treatment aims to prevent that relapse.
This study compares two medicines (tafenoquine and primaquine) taken with chloroquine to treat P. vivax malaria. It aims to see which is safer and works better in Indian participants aged 2 to 64.
This study tests a new vaccine designed to prevent malaria caused by the Plasmodium vivax parasite. It aims to see if the vaccine is safe and produces a good immune response in healthy adults aged 18 to 59.
This study tests a way to clear hidden malaria parasites in people who don't feel sick, to help stop the spread of malaria in Rwanda.
This study tests how well malaria treatments work in Ethiopia. It aims to find the best medicines for uncomplicated malaria caused by certain parasites, helping patients recover fully and preventing future drug resistance.
Hear when a new Malaria Vivax trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.